or Try an Advanced Search...

    Solid Tumors Stocks List

    Symbol Grade Name % Change
    CRIS C Curis, Inc. -4.78
    EBS C Emergent Biosolutions, Inc. -0.46
    ELTX C Elicio Therapeutics, Inc. -0.95
    XOMA C XOMA Corporation 7.39
    KURA C Kura Oncology, Inc. -0.29
    MRUS C Merus N.V. -1.33
    RNXT C RenovoRx, Inc. 7.81
    ADCT C ADC Therapeutics SA -5.91
    XLO C Xilio Therapeutics, Inc. -6.35
    INMB C INmune Bio Inc. -6.96
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Devices Other Shell Companies
    Related Stock Lists: Medicine Cancer Biotechnology Drugs Clinical Medicine Immune System Monoclonal Antibodies Antibodies Cancer Immunotherapy Cancer Treatment Carcinoma Checkpoint Inhibitor Disease Hematological Cancers Immunology Immunotherapies Immunotherapy Lymphoma Multiple Myeloma Non Small Cell Lung Cancer

    Related ETFs - A few ETFs which own one or more of the above listed Solid Tumors stocks.

    Symbol Grade Name Weight
    PTH D Invesco DWA Healthcare Momentum ETF 2.96
    SBIO D ALPS Medical Breakthroughs ETF 2.78
    BBC D Virtus LifeSci Biotech Clinical Trials ETF 2.78
    CNCR D Loncar Cancer Immunotherapy ETF 2.59
    LABD D Direxion Daily S&P Biotech Bear 3X Shares 0.96
    View all Solid Tumors ETFs...
    Compare ETFs
    Compare PTH to LABD Compare SBIO to BBC Compare SBIO to LABD

        Solid Tumors Stocks Recent News

        Date Stock Title
        May 10 XOMA XOMA Corp (XOMA) Q1 2024 Earnings: Misses Revenue Estimates, Reports Lower Net Loss
        May 10 EBS Emergent BioSolutions: High-Risk, High-Reward Strategic Turnaround
        May 10 MRUS Investors push Merus (NASDAQ:MRUS) 5.0% lower this week, company's increasing losses might be to blame
        May 10 CRIS Curis to Present Updated Data from the TakeAim Leukemia Study
        May 10 EBS Emergent BioSolutions to Hold Virtual Annual Meeting of Stockholders on Thursday, May 23, 2024
        May 9 INMB INmune Bio reports Q1 GAAP EPS of -$0.61
        May 9 INMB INmune Bio Inc. Announces First Quarter 2024 Results and Provides Business Update
        May 9 MRUS Merus GAAP EPS of -$0.59 beats by $0.20, revenue of $7.89M misses by $0.45M
        May 9 XOMA XOMA GAAP EPS of -$0.86, revenue of $1.49M
        May 9 XOMA XOMA Reports First Quarter 2024 Financial Results and Highlights Recent Activities
        May 8 INMB INmune Bio Q1 2024 Earnings Preview
        May 8 MRUS Merus Announces Financial Results for the First Quarter 2024 and Provides Business Update
        May 8 CRIS Curis, Inc. (NASDAQ:CRIS) Q1 2024 Earnings Call Transcript
        May 8 EBS Looking Into Emergent BioSolutions's Recent Short Interest
        May 8 KURA 2 Incredible Growth Stocks to Buy Hand Over Fist
        May 8 KURA Kura Oncology to Participate in Bank of America Securities Healthcare Conference
        May 8 CRIS Curis, Inc. (CRIS) Q1 2024 Earnings Call Transcript
        May 7 XOMA Certara, Inc. (CERT) Q1 Earnings Meet Estimates
        May 7 KURA Kura Oncology: Balancing Act Of Promise And Pragmatism
        May 7 XOMA Xoma (XOMA) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Devices Other Shell Companies
        Related Stock Lists: Medicine Cancer Biotechnology Drugs Clinical Medicine Immune System Monoclonal Antibodies Antibodies Cancer Immunotherapy Cancer Treatment Carcinoma Checkpoint Inhibitor Disease Hematological Cancers Immunology Immunotherapies Immunotherapy Lymphoma Multiple Myeloma Non Small Cell Lung Cancer
        Solid Tumors

        Solid tumors are masses of abnormal cells that form when cells in the body divide and grow uncontrollably. They are usually found in the organs, but can also form in the tissues of the body. Solid tumors can be benign (non-cancerous) or malignant (cancerous).

        Browse All Tags